Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus
- PMID: 10888395
- DOI: 10.1016/s1071-3581(00)70013-4
Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus
Abstract
Background: Altered heart and skeletal glucose usage has been reported in patients with non-insulin-dependent diabetes mellitus (NIDDM). Although elevations in plasma free fatty acid (FFA) concentrations have been implicated in reduced myocardial 18fluorine-fluoro-2-deoxy-D-glucose uptake (MFU), the specific role of whole-body insulin resistance in MFU in patients with NIDDM compared with skeletal muscle metabolism remains controversial.
Purpose: MFU and skeletal muscle 18fluorine-fluoro-2-deoxy-D-glucose uptake (SMFU) were compared with positron emission tomography and the whole-body glucose disposal rate (GDR) during hyperinsulinemic euglycemic clamping in 26 normotensive asymptomatic patients with NIDDM who were not taking medication. These factors were also compared in 12 age-matched control subjects to increase the knowledge of the influence of whole-body insulin resistance on MFU. In addition, independent factors for both SMFU and MFU were investigated.
Results: GDR in control subjects (10.0 +/- 2.97 mg/min per kilogram) was significantly higher than in patients with NIDDM (4.05 +/- 2.37 mg/min per kilogram, P < .01). SMFU in patients with NIDDM (0.826 +/- 0.604 mg/min per 100 g) was significantly lower than that in control subjects (1.86 +/- 1.06 mg/min per 100 g, P < .01). MFU in patients with NIDDM (5.35 +/- 2.10 mg/min per 100 g) was also significantly lower than that of control subjects (7.05 +/- 1.66 mg/min per 100 g, P = .0182). SMFU significantly correlated with GDR (r = .727, P < .01) and FFA (r = -.52, P < .01) in patients with NIDDM. MFU also correlated with GDR (r = .778, P < .01) and FFA (r = -.72, P < .01) in patients with NIDDM. Multivariate stepwise regression analysis showed that GDR (F = 36.8) was independently related to MFU (r = .85, P < .01) whereas FFA was not (F = 1.763), where F is the value for statistical analysis of multivariate stepwise regression analysis.
Conclusion: Insulin resistance is the most essential factor for both heart and skeletal muscle FDG uptake in patients with NIDDM.
Similar articles
-
Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.J Nucl Med. 1998 May;39(5):884-9. J Nucl Med. 1998. PMID: 9591594
-
Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.J Nucl Med. 1999 Jul;40(7):1116-21. J Nucl Med. 1999. PMID: 10405129
-
Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.Diabetologia. 1998 May;41(5):555-9. doi: 10.1007/s001250050946. Diabetologia. 1998. PMID: 9628273
-
Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.J Nucl Med. 2001 Jul;42(7):1005-10. J Nucl Med. 2001. PMID: 11438619
-
Insulin action in skeletal muscle from patients with NIDDM.Mol Cell Biochem. 1998 May;182(1-2):153-60. Mol Cell Biochem. 1998. PMID: 9609124 Review.
Cited by
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.Diabetes Care. 2023 Nov 1;46(11):2050-2057. doi: 10.2337/dc23-0871. Diabetes Care. 2023. PMID: 37713581 Free PMC article.
-
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study.Front Cardiovasc Med. 2022 Jun 29;9:924787. doi: 10.3389/fcvm.2022.924787. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35845046 Free PMC article.
-
Changes in Cardiac Metabolism in Prediabetes.Biomolecules. 2021 Nov 12;11(11):1680. doi: 10.3390/biom11111680. Biomolecules. 2021. PMID: 34827678 Free PMC article. Review.
-
Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative 18F-FDG PET-CT in breast cancer: a retrospective cross-sectional study.BMC Cancer. 2021 Oct 27;21(1):1151. doi: 10.1186/s12885-021-08886-2. BMC Cancer. 2021. PMID: 34706697 Free PMC article.
-
Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement.J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):894-902. doi: 10.1002/jcsm.12430. Epub 2019 May 15. J Cachexia Sarcopenia Muscle. 2019. PMID: 31094095 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
